|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 293.45 USD | +0.68% |
|
-0.83% | -26.20% |
| Capitalization | 39.18B 33.56B 30.69B 29.06B 53.81B 3,746B 54.24B 366B 142B 1,780B 147B 144B 6,196B | P/E ratio 2026 * |
39.2x | P/E ratio 2027 * | 27x |
|---|---|---|---|---|---|
| Enterprise value | 36.01B 30.85B 28.21B 26.71B 49.46B 3,443B 49.86B 337B 131B 1,636B 135B 132B 5,695B | EV / Sales 2026 * |
6.41x | EV / Sales 2027 * | 4.63x |
| Free-Float |
99.83% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alnylam Pharmaceuticals, Inc.
| 1 day | +0.68% | ||
| 1 week | -0.83% | ||
| Current month | -5.18% | ||
| 1 month | -13.54% | ||
| 3 months | -6.66% | ||
| 6 months | -34.67% | ||
| Current year | -26.20% |
| 1 week | 284.28 |  | 298.38 |
| 1 month | 284.28 | | 333.39 |
| Current year | 284.28 | | 427.05 |
| 1 year | 280.6 | | 495.55 |
| 3 years | 141.98 | | 495.55 |
| 5 years | 117.58 | | 495.55 |
| 10 years | 31.38 | | 495.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 31/12/2021 | |
Jeffrey Poulton
DFI | Director of Finance/CFO | 58 | 12/08/2019 |
| Chief Tech/Sci/R&D Officer | - | 31/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 80 | 22/04/2012 |
Amy Schulman
CHM | Chairman | 65 | 04/01/2023 |
David Pyott
BRD | Director/Board Member | 72 | 17/12/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.68% | -0.83% | +9.68% | +42.90% | 39.18B | |
| -0.89% | +3.26% | +40.69% | +131.73% | 898B | |
| +0.16% | +3.73% | +57.69% | +43.55% | 556B | |
| +1.09% | +3.98% | +18.78% | +43.23% | 372B | |
| +3.47% | -0.94% | +23.89% | +10.73% | 326B | |
| +0.66% | +3.66% | +36.38% | +15.27% | 287B | |
| +0.97% | +3.81% | +30.26% | +27.24% | 285B | |
| -0.04% | +0.99% | +54.36% | -3.18% | 280B | |
| +0.91% | +1.25% | -30.88% | -49.10% | 207B | |
| -0.07% | +2.17% | +28.20% | +44.34% | 181B | |
| Average | +0.87% | +1.81% | +26.91% | +30.67% | 343.16B | |
| Weighted average by Cap. | +0.91% | +2.33% | +34.02% | +50.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.62B 4.81B 4.4B 4.17B 7.72B 537B 7.78B 52.52B 20.4B 255B 21.08B 20.63B 888B | 7.32B 6.27B 5.74B 5.43B 10.06B 700B 10.14B 68.47B 26.59B 333B 27.49B 26.9B 1,158B |
| Net income | 1.03B 879M 803M 761M 1.41B 98.07B 1.42B 9.59B 3.72B 46.6B 3.85B 3.77B 162B | 1.52B 1.3B 1.19B 1.13B 2.08B 145B 2.1B 14.18B 5.51B 68.93B 5.69B 5.57B 240B |
| Net Debt | -3.17B -2.71B -2.48B -2.35B -4.35B -303B -4.38B -29.6B -11.5B -144B -11.88B -11.63B -501B | -5.26B -4.51B -4.12B -3.9B -7.23B -503B -7.28B -49.19B -19.11B -239B -19.75B -19.33B -832B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/05/26 | 293.45 $ | +0.68% | 889,670 |
| 13/05/26 | 291.48 $ | -0.19% | 975,853 |
| 12/05/26 | 292.03 $ | +2.52% | 826,171 |
| 11/05/26 | 284.84 $ | -3.46% | 1,287,797 |
| 08/05/26 | 295.05 $ | -0.29% | 926,772 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALNY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition